<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Projects on Peter Moravec&#39;s Web Portfolio</title>
    <link>/projects/</link>
    <description>Recent content in Projects on Peter Moravec&#39;s Web Portfolio</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language><atom:link href="/projects/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>A quick introduction</title>
      <link>/projects/introduction/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>/projects/introduction/</guid>
      <description>IntroductionMy name is Peter Moravec and I am currently reading for the Masters in Financial Analysis at London Business School.
What I loveMy biggest passion in life is everything automotive. I have been into cars since I can remember.Going on a road trip through the mountains is my favourite leisure activity
My StrengthsI like to take initiativeTeam playerGood analytical and numerical skillsI enjoy networking</description>
    </item>
    
    <item>
      <title>My Resume</title>
      <link>/projects/cv/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>/projects/cv/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Report</title>
      <link>/projects/report/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>/projects/report/</guid>
      <description>Gilead to acquire Immunomedics for $21bnBy Peter Moravec (London Business School) 14/09/2020
Overview of the deal
Acquirer: Gilead Sciences Inc.Target: Immunomedics Inc.Â Estimated value: $21bnAnnouncement date:Acquirer Advisors: Lazard and Morgan StanleyTarget Advisors: Centerview Partners and BofA Securities
Gilead Sciences, the company, known for its Covid-19 treatment Remdesivir has decided to branch out further into cancer treatment by agreeing to acquire Immunomedics. The two companies were previously in talks about a potential partnership but agreed that the new drug developed by Immunomedics would produce better sales under one firm.</description>
    </item>
    
    <item>
      <title>Session 6: Homework 3</title>
      <link>/projects/movie_ratings/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>/projects/movie_ratings/</guid>
      <description>IMDB ratings: Differences between directorsThe null hypothesis: Mean IMDB Ratings for Steven Spielberg and Tim Burton are the same (p-value =&amp;gt; 0.05)The alternative hypothesis: Mean IMDB Ratings for Steven Spielberg and Tim Burton are not the same (p-value &amp;lt; 0.05)
Replicating plot of confidence intervals for the mean ratings of the two directorsmovies &amp;lt;- read_csv(here::here(&amp;quot;data&amp;quot;, &amp;quot;movies.csv&amp;quot;))glimpse(movies)## Rows: 2,961## Columns: 11## $ title &amp;lt;chr&amp;gt; &amp;quot;Avatar&amp;quot;, &amp;quot;Titanic&amp;quot;, &amp;quot;Jurassic World&amp;quot;, &amp;quot;The Ave.</description>
    </item>
    
  </channel>
</rss>
